Nature has the answer
Using the body's initial defence we create products and systems to use in areas that need infection control, beyond human and animal health. Our formulations and delivery systems offer stable shelf life for pre and post creation.
Efficacy well established for pathogens – bacteria, virus, fungal
Bio-identical: avoids bacterial resistance: cost effective: affordable for 3rd world.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial compound/strategy
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Market entry
- Research
- Validation
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Joint Venture
- Co-develop
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- SSI
- CNSI
- IAI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Money, skills, experience, introductions, shorten time to market
Start up using nature’s chemistries for infection control including ABR and delivery systems for industries needing infection control beyond medical
Whilst we have ideas for other products and derivatives, these have not yet been pursued.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!